A B S T R A C T

Background
Total knee replacement has been demonstrated to be one of the most successful procedures in the treatment of osteoarthritis. However quadriceps weakness and reductions in function are commonly reported following surgery. Recently Neuromuscular Electrical Stimulation (NMES) has been used as an adjunct to traditional strengthening programmes. This review considers the effectiveness of NMES as a means of increasing quadriceps strength in patients before and after total knee replacement.
Objectives
To assess the effectiveness of NMES as a means of improving quadriceps strength before and after total knee replacement. 
Search methods
We searched The Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1950 to
January
Selection criteria
Randomised controlled trials and controlled clinical trials were accepted that used NMES for the purpose of quadriceps strengthening either pre or post total knee replacement.
Data collection and analysis
Two review authors decided which studies were suitable for inclusion based on the inclusion and exclusion criteria in the protocol and the data was extracted using pre-developed data extraction forms. Two review authors (BM and BC) independently assessed the methodological quality of the included trials using a descriptive approach as advocated by the Musculoskeletal group. Only two studies were included in the review. Neither study presented results in a form suitable for meta-analysis. The authors of both studies were contacted to obtain the raw data but they were no longer available.The data from both studies are described in the review.
Main results
Two studies were identified for inclusion in the review. No significant differences were reported in either study for maximum voluntary isometric torque or endurance between the NMES group and the control group but significantly better quadriceps muscle activation was reported in the exercise and neuromuscular stimulation group compared with the exercise group alone in the second study. This difference was significant at the mid training (six week) time point but not at the twelfth week post training time point. Further analysis of both studies were not possible due to the absence of raw data scores. Both studies carried a high risk of bias. Mean values were not given for strength, endurance, cross sectional area or quality of life. Pain outcomes, patient satisfaction or adverse effects were not reported in either study. The results were presented as percentage improvements from baseline and the number of subjects in each group was unclear.
Authors' conclusions
The studies found in this review do not permit any conclusions to be made about the application of neuromuscular stimulation for the purposes of quadriceps strengthening before or after total knee replacement. At this time the evidence for the use of neuromuscular stimulation for the purposes of quadriceps strengthening in this patient group is unclear.
P L A I N L A N G U A G E S U M M A R Y
Electrical stimulation for thigh muscle strengthening before and after knee replacement surgery
This summary of a Cochrane review presents what we know about the effect of electrical stimulation as a treatment to improve the strength of the thigh muscles before and after knee replacement surgery.
The review shows that we are uncertain whether electrical stimulation affects thigh muscle strength before and after knee replacement surgery because of the very low quality of the evidence.
What is thigh muscle weakness and what is electrical stimulation?
Osteoarthritis of the knee can make the knee joint painful and unstable. Knee replacement surgery is a treatment that can sometimes help this condition. One side effect of having knee surgery, is that people can lose strength in their thigh muscles. When your thigh muscles are weak, it can be difficult to stand from a sitting position. Up to a year later, some people walk and climb stairs more slowly than they did before surgery.
Electrical stimulation means using electricity to make the thigh muscle contract, just as it would if a person were exercising. Electrodes are wires that send the electrical current from a small machine to your thigh muscle. Usually, a doctor or physiotherapist will connect electrodes with tape to the skin on your thigh. The treatment is usually given as part of an overall exercise program.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement . These studies reported reduced strength as expected but also reported reduced muscle activation levels in the pre surgical population when compared either with their non-affected knee or with normal control groups. Beaupre 2004 reported no difference in strength outcomes in a group subjected to a pre operative exercise programme when compared with a control pre operative knee replacement group. These findings are similar to those reported by (Mizner 2005b) with the post operative knee replacement group. In the pre operative group, inadequate activation may also contribute to the poor response to traditional strengthening programmes. Since NMES can enhance muscle activation in addition to improving strength, its investigation as an adjunct to rehabilitation is valid in both the preoperative and post operative total knee replacement populations. Pre operative quadriceps strength has been shown to be a predictor of functional ability at one year post total knee replacement (Mizner 2005c).
Some studies suggest that electrical stimulation may activate a greater proportion of type 2 or fast twitch muscle fibres than a voluntary contraction and thus produce higher levels of force production (Delitto 1990; Ward 2002). Trimble 1991 stated that NMES activated faster contracting motor units preferentially, some of which would only be activated at high exercise levels during a voluntary contraction. However, much debate exists in the literature regarding the mechanisms by which NMES affects fibre recruitment (Gregory 2005). Some evidence supports NMES as a means of increasing quadriceps strength after knee surgery in other clinical populations (Snyder-Mackler 1994a). Reflex inhibition has also been documented in this patient group (Snyder-Mackler 1994b).
How widely NMES is used post total knee replacement is not documented in the literature although anecdotal reports claim it is used frequently. There are reports of its use as an adjunct to therapy in people with quadriceps weakness in both outpatient and inpatient settings. NMES is widely available and is inexpensive to provide. Given the specific nature of quadriceps weakness in people both pre and post total knee replacement it may provide a valuable addition to traditional strengthening programmes in both populations. This systematic review will assess the effectiveness of NMES in improving quadriceps strength in the pre and post operative knee replacement population. It will explore in detail the parameters of the currents used for muscle strengthening. Specifically the frequencies, waveforms, contraction times, ramp times, electrode placements and current intensities which maximise improvements in quadriceps strength both generally and specifically pre and post total knee replacement will be evaluated.
O B J E C T I V E S
The primary objective was to assess the effectiveness of surface neuromuscular electrical stimulation (NMES) for quadriceps strengthening when administered pre and/or post total knee replacement.
Specific Objectives
1. To compare the effectiveness of NMES administered in different ways, including the frequency used, the intensity, or duration of treatment sessions, and its effect on the activation and strength of the quadriceps muscle in patients pre and/or post total knee replacement.
2. To compare, if possible the effectiveness of the addition of NMES in the pre operative stage on muscle strength and activation, the effectiveness of NMES in the post operative stage, and the effectiveness of NMES if applied in both stages.
3. To examine the published literature on NMES as it relates to clinical practice in the total knee replacement client group. The hypotheses are:
• that NMES is better than no treatment in improving quadriceps strength either pre and/or post total knee replacement;
• that NMES is better than traditional active muscle strengthening programmes in the pre and/or post knee replacement surgical group;
• that NMES added to a rehabilitation programme is better than a rehabilitation programme without NMES in people pre and/or post total knee replacement.
M E T H O D S Criteria for considering studies for this review Types of studies
Randomised control trials and controlled clinical trials.
Types of participants
This review included all studies involving adults who had either had or were listed for cemented or un cemented total knee prostheses for osteoarthritis. Participants must have had their quadriceps strength assessed pre and post NMES intervention. All subjects were eligible regardless of their age, range of movement or level of strength. All adults were included who had NMES as a treatment or part of treatment in any setting from one year pre surgery to one year post surgery. Participants pre surgery must have been listed for surgery. Participants were excluded if they had undergone revision total knee replacement, unicompartmental replacement or if they have any history of inflammatory diagnosis such as rheumatoid arthritis or ankylosing spondylitis, or had any history of nerve palsy pre, post or intraoperatively.
Types of interventions
Studies which used NMES (at any frequency, duration, and intensity) were included when used for the purpose of muscle strengthening, or to induce changes in muscle activation. The parameters given in each study were carefully scrutinized to ensure a strengthening effect was possible that is that the current application was capable of causing a tetanic contraction at 35% to 50% of the client's maximum volitional isometric contraction thus the patients maximum isometric contraction needed to be recorded. Studies of NMES in combination with any other intervention or active muscle strengthening programme were also included. NMES parameters were assessed using the primary and secondary outcome measurements outlined. NMES for the purpose of pain relief with transcutaneous nerve stimulation (TENS) were not included.
Types of outcome measures Primary outcomes
Quadriceps strength, endurance, or power as measured by validated assessment tools. 
Secondary outcomes
Length of stay in either acute hospital and/or rehabilitation facility. Pain scores. McGill pain score. Where possible treatment outcomes were measured pre and post NMES intervention within one year pre and post surgery. Depending on the data reported outcomes will be evaluated on a weekly basis during the first month and every month thereafter pre and post surgery.
Search methods for identification of studies
See: Cochrane Musculoskeletal Group methods used in reviews.
Electronic searches
The 
Searching other resources
We scanned the reference lists of articles, review papers and textbooks for additional references. In addition ClinicalTrials.gov was searched for unpublished and/or ongoing clinical trials. Published and unpublished dissertations (using for example, UMI/ProQuest and NDLTD) were also searched. 
Selection of studies
Two authors (BM and BC) independently selected trials for inclusion, extracted data, assessed trial quality and analysed the results. If there were disagreements it was planned a third author (DOM) would be consulted. This was not necessary. Data was not included in the review until a consensus was reached. Both review authors screened the titles and the abstracts of all publications obtained by the search strategy. The full text of all included articles and those deemed unclear from the abstract were obtained. Data were extracted from all studies fulfilling the inclusion criteria, including data concerning methodological issues, characteristics of participants, interventions to include NMES frequency, intensity, pulse duration, waveform, contraction times, relaxation times and all recorded outcome measures. If there was sufficient detail provided in the studies identified it was proposed to explore the effectiveness of NMES in groups stratified in terms of the degree of muscle weakness reported pre and post intervention. Insufficient studies were identified to do this. In order to carry out this subgroup analyses a sufficient number of studies reporting objective measurement of muscle strength pre and post intervention needed to have been identified. The data was extracted independently using a standard data extraction form.
Assessment of risk of bias in included studies
Two review authors (BM and BC) independently assessed the methodological quality of the included trials using a descriptive approach as advocated by the Musculoskeletal group (Tugwell 2004) . The methodological quality of all included trials was assessed using a standard form. 1. Concealment of treatment allocation 2. Blinding of intervention provider, recipient and outcome assessor 3. Handling of withdrawals and dropouts: a. Accounting for the numbers -were the number of withdrawals and dropouts reported for both groups? b. Accommodating withdrawals (intention to treat/imputation) -were the number of withdrawals and dropouts accounted for in the analysis (for example through intention to treat or last observation carried forward)? Definitions for allocation concealment A. Adequate concealment -allocation of participants to different groups was not known until the point of allocation (e.g. sequentially numbered, sealed, opaque envelopes; onsite computer system with locked, unreadable files). B. Unclear concealment (e.g. stating only that a list or table was used). C. Inadequate concealment -transparent before allocation (e.g. alternating sequence; case record numbers; dates of birth or days of the week). D. Not used -clear that allocation concealment was not used. All components of the checklist will be individually assessed as to whether they (A) are met (B) are not met or (C) are unclear. In February 2008 following publication of the protocol for this review the handbook for systematic reviews was updated. In addition to the method of assessment of methodological quality described above the updated tool for assessing risk of bias (Higgins 2008) was included. The criteria described for judgement of risk of bias, that is describing criteria as 'Yes' (i.e. low risk of bias), 'No' (i.e. high risk of bias) or Unclear (uncertain risk of bias) uses the criteria outlined in the risk of bias assessment tool as described by Higgins 2008. Summary assessments for each study are described within each study as low, unclear or high risk of bias depending on the findings in each domain (Higgins 2008). Independent quality assessment using separate, pre-piloted, forms was undertaken by two review authors (BM) and (BC). Where differences in opinion could not be resolved, it was planned to have arbitration by a third review author (DOM). This was not necessary. Masking of trial identifiers such as authors and journal names was not carried out. Initial inter-observer reliability of both the screening (include or exclude) and quality assessment on a limited sample of papers demonstrated the two authors graded the methodological quality without disagreement. This high level of agreement in the pilot test phase resulted in no changes to the data extraction form. These studies were drawn from a pool of studies that did not meet the inclusion criteria.
Assessment of reporting biases
It was planned that data would be plotted on a funnel graph in RevMan to allow assessment of publication bias. This was not done as there were insufficient numbers of studies identified.
Data synthesis Dichotomous data
In the analysis of dichotomous data it was intended that the risk ratio would be calculated with 95% confidence intervals according to intention-to-treat principles, and using the assumption that patients who dropped out had a negative outcome. If meta-analysis had been deemed to be appropriate, a fixed effect model of metaanalysis would have been preferred but the DerSimonian and Laird random effects method would have been used if heterogeneity was present. However if substantial heterogeneity had been found in terms of clinical diversity for example in differences in dose or duration of contraction and/or relaxation periods or differences in neuromuscular stimulation or differences in outcome assessment, meta-analysis would be deemed inappropriate. In this review there were no studies identified which were suitable for meta-analysis. It was intended that if meta-analysis was not appropriate, subgroup analysis would then be completed for these parameters. However an insufficient number of studies was identified in this review for subgroup analysis. To assess for heterogeneity it had been proposed that the I 2 statistic would be used where I 2 = [(Q-DF)/Q] X 100% where Q is the chi squared statistic and df is its degrees of freedom (Higgins 2002; Higgins 2003) . This describes the percentage of variability of effect that is due to heterogeneity rather than chance (Higgins 2005). A value greater than 50% would have been considered substantial heterogeneity and metaanalysis would then not be performed. However in this review no studies were identified where it was possible to use the statistic and heterogeneity was not tested.
Continuous data
It had been proposed that continuous data would be analysed if the mean and the standard deviation values were presented. If the standard deviation was not reported this value would be calculated from standard errors, confidence intervals, t statistics or P values, if available. It was intended to test for skewness prior to metaanalysis. It was proposed that the standard deviations and the means would be reported or obtained from the authors and the standard deviation when multiplied by two should be less than the mean. If the mean had been found to be less than the standard deviation multiplied by two the mean would have been unlikely to be an appropriate measure of the centre of distribution and the sample would have been said to be skewed (Altman 1996). If skewness had been found, meta-analysis would not be performed on those studies with small sample sizes. It was proposed that with normally distributed data the weighted mean difference would be used for continuous data using the same measurement scales and the standardised mean difference will be used for continuous outcomes using different scales.
Grading of evidence
In February 2008 following publication of the protocol for this review the handbook for systematic reviews was updated. The grading system to rank the evidence in the systematic review has been modified. The Cochrane Collaboration has adopted the principles of the GRADE system for evaluating the quality of evidence for outcomes reported in systematic reviews (Schünemann 2008) and this system is also recommended by the Musculoskeletal group. Both studies included in this review although described as randomised are quality rated as low due to limitations in the study design and imprecision in the results section. However as the overall results of the review are inconclusive there is no grade overall given for the quality of the body of evidence.
Clinical relevance tables
Clinical relevance tables were planned to be compiled under additional tables to improve the readability of the review. For dichotomous outcomes, the weighted absolute risk difference would be calculated using the risk difference (RD) statistic in RevMan. RR-1 calculates the weighted relative percent change. The number needed to treat (NNT) would be calculated from the control group event rate, i.e. the rate of events in the control group (unless the population event rate is known) and the relative risk using the Visual Rx NNT calculator (Cates 2004). Continuous outcome tables were also planned to be presented under additional tables. Weighted absolute change would be calculated from the weighted mean difference (WMD) statistic in RevMan when trials using the same scale are pooled. For outcomes pooled on different scales, the standardized mean difference (SMD) would be multiplied by the baseline standard deviation in the control group to obtain the weighted absolute change. Relative percent change from baseline would be calculated as the absolute benefit divided by the baseline mean of the control group. NNT was planned to be calculated using the Wells calculator software available at the CMSG editorial office. The minimal clinically important difference (MCID) for each outcome was planned to be determined for input into the calculator.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of ongoing studies. Electronic and manual searches identified a total of seven hundred and six citations of which fifteen abstracts were selected as being potentially relevant. Full text papers were sought for 14, one paper could not be located with the reference supplied (Zizic 1995). Two studies met the criteria for inclusion in the review (Oldham 1995; Stevens 2002). The study by Oldham 1995 had 30 participants, 13 male and 17 female with a median age of 69 years (range 57 to 77 years). They were recruited from a waiting list of people awaiting knee replacement surgery. This study compared the effect of patterned neuromuscular stimulation (PNMS) with uniform neuromuscular stimulation, random neuromuscular stimulation and sham stimulation on the strength, endurance, cross sectional area, function, and quality of life of people waiting for knee replacement surgery (end stage osteoarthritis). The PNMS group received a pattern of stimulation replicating the discharge of a fatigued quadriceps femoris motor unit. The random NMS group received a stimulation pattern generated by randomly shuffling the inter pulse intervals in the fatigued motor unit, and the uniform group were stimulated at the same mean rate as the PNMS and random groups i.e. 8.4Hz. The sham group received stimulation comprising a single 33 microsecond impulse every three minutes. The waveform was asymmetrical biphasic, the contraction time was 30 seconds on and the relaxation time was 15 seconds for all groups. The treatment intensity was the minimum required to produce a visible and palpable muscle contraction although there was no assessment of the individual's maximum voluntary contraction reported. It is therefore unclear if these parameters could effect muscle strength. Subjects stimulated their weaker quadriceps for three consecutive hours per day for six weeks. The outcome measurements were reported as being taken by experienced clinical staff but it is unclear whether or not the staff were blinded or independent. Maximum quadriceps voluntary isometric torque, quadriceps endurance, timed sit-to-stand, walking velocity, stride length and quality of life outcomes are reported. All results are presented graphically as percentages in change from baseline. No numerical data were provided on the number of clients in each group or the group means or standard deviations. No raw data were presented in table form independently of the graphical presentation. The author was contacted but none of the raw data was still available. Two patients withdrew from the study at weeks 7 and 11 and it is unclear to which group they were originally allocated to. Stevens 2002 had 39 participants. All were post primary, unilateral, total knee arthroplasty with 18 participants in the control group and 16 in the experimental group. There were 12 males and six females in the control group of average age 63.7 years. The experimental group had 12 males and 4 females and the average age was 65.9 years. The body mass index in the control group was 30.2 ± 3.2kgs in the control group and 28.6 ± 4.6kgs in the experimental group. This study compared the effectiveness of a rehabilitation programme incorporating neuromuscular electrical stimulation (NMES) with high-intensity voluntary exercise against high-intensity voluntary exercise alone. Both groups participated in identical exercise programmes but the NMES group also received 10 NMES elicited quadriceps contractions during each treatment session at a dosage ranging from 29% to 69% of their maximum voluntary isometric contractions. The outcome assessors were blinded to group allocation and assessed quadriceps strength and activation together with functional testing, health status questionnaires at initial evaluation, and in the 3rd, 9th and 12th week post surgery.
Risk of bias in included studies
Both studies carried an overall high risk of bias See Figure 1 . Oldham 1995 stated it was a randomised control trial, but the randomisation process was not described. Thus the risk of bias in sequence generation must be judged as unclear. Similarly, insufficient information was given about allocation concealment and the risk of bias there is also unclear. Whilst the study is described as being double blinded, no information was given about who was blinded or how. The level of potential bias in the blinding must also be deemed unclear. Two patients in the study are reported as dropping out at 7 and 11 weeks and it is not possible to identify which of the four groups these subjects were from. The study does not address how incomplete data was dealt with again rendering the potential for bias from incomplete outcome data as unclear.
In conclusion the selective reporting of outcomes with no group means presented and results given as graphical representation of percentage improvement from baseline does not allow for outcomes to be entered in a meta-analysis. This demonstrates potential for a high risk of bias. In addition the absence of raw data to illustrate the baseline outcome measurements does not allow us to assume the groups were similar at baseline. This is an additional threat to the validity of the study and overall his study demonstrated a high risk of bias. Stevens 2002, like the study of Oldham 1995 gives no information on how the randomisation process was carried out. The risk of bias in sequence generation therefore is unclear. No method of concealment allocation was described and therefore the potential for bias here is also unclear. Although it was stated that the outcome assessments were carried out by those blinded to the study question, it was no stated whether or not the subjects or the treating therapists were blinded, this potentially introduces a high risk of bias in the study. Although the patients who did not complete the study were accounted for it is not clear to which groups these subjects were initially allocated, making it unclear whether or not there is a risk of bias from incomplete data. The results in this study are presented as repeated measurements of analysis of variance (ANOVA results) and there are no mean group values or standard deviations presented. The findings were thus not presented in a form suitable for meta-analysis. Thus overall there is potentially a high risk of bias in this study.
Effects of interventions
See: Summary of findings for the main comparison Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement No significant differences were reported in the study by Oldham 1995 for maximum voluntary isometric torque or endurance between groups. No significant differences were reported in function or quality of life. Further analysis of the study findings was not possible due to the absence of raw data scores. Mean values were not given for strength, endurance, cross sectional area or quality of life. The results are presented as percentage improvements from baseline and the number of subjects in each group is unclear. The author was contacted with regard to the raw data but this was no longer available. No significant differences in the quadriceps index were reported between the NMES and exercise groups in the study by Stevens 2002. Significantly better quadriceps muscle activation was reported in the exercise and neuromuscular stimulation group compared with the exercise group alone. This difference was significant at mid training at six weeks but not at twelve weeks post training. The repeated measures ANOVA indicated significant differences in the timed up and go test but there were no significant differences in univariate ANOVA scores at any time. No significant differences were reported at any time in the response to the other health status questionnaires. Further analysis of the outcomes of this study was not possible as the mean group values were not given and the standard deviation values could not be extracted from the P values. The author was contacted to obtain the raw data but it was no longer available. Pain outcomes, patient satisfaction or adverse effects were not reported in either study.
D I S C U S S I O N Summary of main results
Although the main findings reported in both included studies were not significant for quadriceps strength, the two studies included in this review have a high risk of bias due to limitations in the study design and imprecision in the results presented. This would indicate a serious weakness in the confidence in the study findings.
In addition the data in the studies were not presented in a format allowing meta-analysis to be conducted. The summary of findings table is incomplete and therefore the current evidence base is inconclusive. In addition the study by Oldham 1995 did not assess the subjects maximum voluntary contraction pre treatment therefore it is not possible to assess if a muscle strengthening effect could be obtained with the dosage applied.
Overall completeness and applicability of evidence
The data from the studies identified does not allow any conclusion to be made with regard to the use of neuromuscular stimulation pre or post total knee arthroplasty. This review is therefore inconclusive regarding the effectiveness of neuromuscular stimulation and further evidence is required to support or negate the use of neuromuscular electrical simulation as a means of quadriceps strengthening pre or post total knee replacement. The authors are aware that this review topic is the subject of ongoing research and the review will be updated to accommodate new evidence as it becomes available.
Quality of the evidence
The current body of evidence does not support or negate the use of neuromuscular electrical stimulation pre or post total knee replacement. The two studies included in the review had 69 subjects in total. Both studies had a high risk of bias and the results presented were incomplete and did not allow any meta-analysis to be conducted. The results of the review are therefore inconclusive.
Potential biases in the review process
Due to the timeframe within which this review was written it is acknowledged that the evidence considered for inclusion was published prior to December 2008. Relevent studies published after that date have therefore not been included but will be included in the next review update. This limitation of the review is acknowledged by the authors as a potential source of bias but is due to the constraints of the editing process.
Agreements and disagreements with other studies or reviews
The authors are unaware of any other systematic review specifically on this topic
Implications for practice
The studies found in this review do not permit any conclusions to be made about the application of neuromuscular stimulation for the purposes of quadriceps strengthening pre or post total knee arthroplasty. At this time the evidence for the use of neuromuscular stimulation for the purposes of quadriceps strengthening in this patient group is unclear.
Implications for research
Well designed randomised controlled trials that compare quadriceps strength pre and post neuromuscular stimulation in both the pre and post total knee arthroplasty groups are needed. It is imperative that future studies assess quadriceps strength pre and post neuromuscular stimulation using reliable and valid assessment tools. It is important that the dosage of neuromuscular stimulation is stated clearly in the study design and its relationship to the clients maximum voluntary contraction is clarified. It is also critical that appropriate study designs are used and that the outcomes are presented in a manner suitable for meta-analysis. Future studies should also consider patient orientated outcomes including functional performance and self reported measures.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Oldham 1995
Methods
A pre test, post test randomised double blind control group design. There were 30 subjects randomly assigned to one of four groups. Patterned neuromuscular stimulation (PNMS) group received a pattern of stimulation replicating the discharge of a fatigued quadriceps femoris motor unit (QFMU), uniform frequency neuromuscular group received stimulation with the same mean rate as the PNMS stimulation (8.4Hz), random pattern neuromuscular stimulation received a stimulation pattern generated by randomly shuffling the inter pulse intervals in the fatigued QFMU and the sham stimulation group received stimulation comprising a single 300 microsecond impulse every three minutes Participants All subjects were recruited from a waiting list of people listed for knee replacement surgery. There were 13 male and 17 females with a median age of 69 years (range 57 to 78). There were 30 subjects in total although the numbers allocated to each group were not specified Interventions All subjects stimulated their quadriceps using a pre-set programme of neuromuscular stimulation for three consecutive hours per day for 6 weeks. Output intensity was set by the subjects as the minimal intensity required to produce a visible and palpable muscle contraction Outcomes Strength, endurance, cross sectional area, timed 10 meter walk, timed sit to stand and quality of life using part two of the Nottingham health profile was recorded
Notes
The results are presented as percentage change values in isometric torque, quadriceps endurance, timed sit to stand, mean velocity of walking, and mean stride length graphically. No numerical data were provided. The author was contacted but the raw data were no longer available. Interpretation of results directly from the graphs was not attempted. There was no significant difference reported between the frequencies with regard to strength and endurance and no significant difference between frequencies for function, cross sectional area and quality of life
Risk of bias
Item
Authors' judgement Description
Adequate sequence generation? Unclear Trial stated as randomised but no method described. Free of other bias? Unclear Insufficient information was given to assess whether or not the groups were similar at baseline. Thus the overall risk of bias is uncertain
Stevens 2002
Methods This study was a randomised control trial with participants allocated to either an 'exercise group' or an 'exercise and neuromuscular stimulation' group for 6 weeks post total knee replacement Participants 39 participants post primary total knee arthroplasty randomly assigned to one of two treatment groups. The control group received voluntary exercise only with exercises twice daily, 5 days per week and the neuromuscular stimulation group received the same exercise programme plus 10 NMES quadriceps contractions at each treatment session. There were 18 participants (12 male and 6 female) in the control group aged in years 63.7 ± 7.7, and 16 participants in the experimental group (12 male and 4 female) aged 65.9 ± 7.6 years in the experimental group Interventions Participants received 6 weeks of treatment 3 times weekly with both groups participating in a high intensity exercise programme. The NMES group also received 10 NMES quadriceps contractions at greater than 30% of quadriceps strength.This consisted of ten, 10 second isometric contractions with an 80 second rest between contractions. The intensity was set to the maximum intensity tolerated by the participant with the dosage ≥ 30% of the voluntary quadriceps strength 
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